Tropical Medicine Research Institute
Khartoum, Khartoum State, 11111, Sudan
NCT Number: NCT00646126
The malaria parasite Plasmodium falciparum remains at sub-patent level throughout the dry season in areas of seasonal malaria transmission. Targeting this parasite reservoir before the transmission season could be a good strategy for malaria control. We are conducting a randomized double blind placebo controlled mass drug administration trial in eight village to clear the dry season low level parasitaemia with an ultimate aim of controlling malaria in eastern Sudan.
Looking for future studies?
Notify Me1 year and older
All sexes
Interventional
Phase 3
Khartoum, Khartoum State, 11111, Sudan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standard three day regimen
Dosage similar to active drug(standard three days regimen)
Time frame: October to December 2006
Tropical Medicine Research Institute
Other
Validation of the Use of Istope-Based Molecular Techniques for Malaria Control
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07027722
Antimalarials, Artemisinins
Saint-Denis, France
View Trial DetailsNCT04661579
Infections, Malaria
Kisumu, Kisumu County, Kenya
View Trial DetailsNCT06300970
Infections, Malaria
Sinje, Grand Cape Mount County, Liberia
View Trial DetailsNCT03172221
Diagnoses Disease, Disease
Quibdó, Colombia
View Trial Details